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Fat and carbohydrate are the principal substrates that
fuel aerobic ATP synthesis in human skeletal muscle. The
relative utilisation of fat and carbohydrate during
exercise can vary enormously and depends strongly on
exercise intensity. An early stable isotope tracer study
(Romijn et al. 1993), which used assumptions to estimate
indirectly the oxidation rate of plasma free fatty acids
(FFAs), suggested that plasma FFAs provide the majority
of the substrate oxidised by skeletal muscle during low-
and moderate-intensity (25 and 65 % of maximal oxygen
uptake capacity, VO2,max) exercise. In addition, it was
suggested that whole-body fat and plasma FFA oxidation
rates declined during high-intensity exercise (85 % VO2,max),
as muscle glycogen became the main fuel source utilised
(Romijn et al. 1993). The primary aim of the present study
was, therefore, to quantify accurately the oxidation rates
of plasma FFA, triacylglycerol (TG; sum of intramuscular
and lipoprotein-derived TG), plasma glucose and muscle
glycogen during steady-state exercise at three intensities
(40, 55 and 75 % of maximal workload, Wmax) using
contemporary stable isotope tracer methodology (i.e. using
direct measurements of plasma FFA oxidation and
validated assumptions for plasma glucose oxidation).
Understanding the regulation of fuel selection in human
skeletal muscle is important, especially as fuel use
abnormalities are present in metabolic diseases like type 2
diabetes (Kelley & Simoneau, 1994; Martin et al. 1995) and
obesity (Colberg et al. 1995). However, the mechanisms
that regulate the relative contribution of carbohydrate
and fat during exercise have not been fully elucidated, and
remain open to discussion. Randle et al. (1963) proposed
the ‘glucose–FFA cycle’ in an effort to explain the
reduction in muscle carbohydrate oxidation rate in the
presence of high plasma FFA levels in resting muscle. It
was proposed that an increased availability of plasma FFAs
could stimulate fat oxidation and decrease carbohydrate
oxidation by suppressing pyruvate dehydrogenase
complex (PDC) activation (via a rise in the mitochondrial
acetyl-CoA/CoA ratio) and by decreasing glycolytic flux
(via the inhibitory effect of high citrate concentrations on
phosphofructokinase activity). According to this concept,
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1. Contemporary stable isotope methodology was applied in combination with muscle biopsy
sampling to accurately quantify substrate utilisation and study the regulation of muscle fuel
selection during exercise.
2. Eight cyclists were studied at rest and during three consecutive 30 min stages of exercise at
intensities of 40, 55 and 75 % maximal workload (Wmax). A continuous infusion of
[U-13C]palmitate and [6,6-2H2]glucose was administered to determine plasma free fatty acid
(FFA) oxidation and estimate plasma glucose oxidation, respectively. Biopsy samples were
collected before and after each exercise stage.
3. Muscle glycogen and plasma glucose oxidation rates increased with every increment in exercise
intensity. Whole-body fat oxidation increased to 32 ± 2 kJ min_1 at 55 % Wmax, but declined at
75 % Wmax (19 ± 2 kJ min
_1). This decline involved a decrease in the oxidation rate of both
plasma FFA and triacylglycerol fat sources (sum of intramuscular plus lipoprotein-derived
triacylglycerol), and was accompanied by increases in muscle pyruvate dehydrogenase complex
activation and acetylation of the carnitine pool, resulting in a decline in muscle free carnitine
concentration.
4. We conclude that the most likely mechanism for the reduction in fat oxidation during high-
intensity exercise is a downregulation of carnitine palmitoyltransferase I, either by this
marked decline in free carnitine availability or by a decrease in intracellular pH.
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the relative utilisation of fat and carbohydrate is
determined primarily by the availability of plasma
FFAs. We therefore investigated whether the rate of
appearance (Ra) of plasma FFAs and their concentration
declined during high-intensity exercise. Earlier studies
(Dyck et al. 1993; Romijn et al. 1995) failed to find
evidence that plasma FFA availability limited fat
oxidation during high-intensity exercise.
More recently, it was hypothesised that high glycolytic
flux rates during high-intensity exercise could limit long-
chain fatty acid oxidation (Dyck et al. 1993; Sidossis et al.
1997; Odland et al. 1998). High glycolytic flux is known to
lead to the accumulation of acetyl-CoA (Constantin-
Teodosiu et al. 1991; Dyck et al. 1993), and via subsequent
increases in the cytosolic production of malonyl-CoA has
been proposed to inhibit carnitine palmitoyltransferase I
(CPT I), and thereby limit long-chain fatty acid entry
into mitochondria. However, it has been found that
muscle malonyl-CoA concentrations do not increase in rat
and human skeletal muscle during high-intensity exercise
(Rasmussen & Winder, 1997; Odland et al. 1998; Dean et
al. 2000); this mechanism is therefore unlikely to lead to a
reduction in fat oxidation.
A third mechanism that could explain the decrease in fat
oxidation that occurs during high-intensity exercise
involves the availability of muscle carnitine. Carnitine is
a co-factor that is required for the transport of long-chain
fatty acids across the inner mitochondrial membrane and
is therefore essential for the oxidation of fatty acids in
the mitochondria. This functional relationship between
carnitine concentration and fat oxidation capacity is not
new and has been previously described in vitro (Fritz,
1955; Cederblad et al. 1976). Furthermore, other studies
have demonstrated a continuous accumulation of muscle
acetylcarnitine with increasing exercise intensity (Harris
et al. 1987; Hiatt et al. 1989). These findings are consistent
with the concept that carnitine acts as a sink for acetyl
group storage during conditions such as a high flux
through the PDC reaction (i.e. when the rate of acetyl
group production exceeds its rate of utilisation by the
tricarboxylic acid (TCA) cycle; Sahlin, 1990; Constantin-
Teodosiu et al. 1991; Timmons et al. 1996, 1998; Howlett
et al. 1998, 1999). Our third aim, therefore, was to
determine whether the decline in free carnitine
concentration that is observed during incremental steady-
state exercise, which occurs as a result of acetylation of
the carnitine pool, is of sufficient magnitude to limit CPT
I activity and fat oxidation.
We tested our objectives during incremental exercise in
trained human subjects using an integrated approach,
combining contemporary tracer methodology (in order to
quantify the components of whole-body substrate
utilisation) and muscle biopsy sampling (in order to
quantify muscle intermediary metabolism). The
information gained from this study is important to our
understanding of the mechanisms responsible for the
integration of carbohydrate and fat oxidation during
exercise, and to our understanding of the metabolic
defect(s) that cause(s) the impairment of fat oxidation in
subjects with type 2 diabetes (Kelley & Simoneau, 1994;
Martin et al. 1995) and obesity (Colberg et al. 1995).
METHODS
Subjects
Eight male cyclists (age, 22.1 ± 0.7 years; body mass, 74.5 ± 2.2 kg;
VO2,max, 5.48 ± 0.16 l min_1; and Wmax, 413 ± 9 W) participated in this
study. Subjects were informed about the nature and risks of the
experimental procedures before their informed consent to participate
was obtained. This study was approved by the local ethical
committee and conformed to the standards set by the Declaration of
Helsinki.
Pre-testing
Wmax and VO2,max were measured on an electronically braked cycle
ergometer (Lode Excalibur; Groningen, The Netherlands) during an
incremental exhaustive exercise test (Kuipers et al. 1985) 1 week
before the first experimental trial.
Diet and activity prior to testing
All subjects consumed a standardised meal (85 kJ (kg body weight)_1)
consisting of (in units of the percentage of the total energy
supplied by the entire meal, En%) 69 En% carbohydrate, 15 En%
fat and 16 En% protein, the evening before the trials. All subjects
were instructed to refrain from heavy physical labour 2–3 days prior
to testing.
Experimental trials
Each subject performed two similar trials, separated by at least
7 days. Each trial consisted of 60 min of resting measurements
followed by 90 min of cycling exercise divided over three 30 min
stages at an exercise intensity of 40, 55 and 75 % Wmax. In one trial,
[U-13C]palmitate and [6,6-2H2]glucose were infused and breath
samples, blood plasma samples and muscle biopsy samples were
collected to quantify the use of different substrate sources and to
determine changes in intramuscular levels of various metabolites
during exercise at different workloads. The second trial was
performed to determine the acetate recovery factor to correct [U-
13C]palmitate oxidation rates for the loss of label by way of isotopic
exchange reactions in the TCA cycle (Sidossis et al. 1995a,b;
Schrauwen et al. 1998). During this trial [1,2-13C]acetate was infused
and breath samples were collected. In order to further validate our
findings four subjects also volunteered to perform three additional
trials. These trials consisted of 60 min of exercise at 40 or 55 % Wmax,
or 30 min at 75 % Wmax, and were performed to investigate whether
total fat and carbohydrate oxidation rates were different during the
sequential exercise stages of the incremental protocol compared to
steady-state exercise at each of the individual intensities.
Protocol
Subjects reported at the laboratory at 08.00 h, after an overnight
fast. A Teflon catheter (Baxter, Utrecht, The Netherlands) was
inserted into an antecubital vein of one arm for blood sampling, and
a second catheter was inserted into the contralateral arm for isotope
infusion. At 08.30 h a resting blood sample was drawn and expired
gases were collected into Vacutainer tubes (Becton Dickinson,
France). Subjects were then administered a single intravenous dose of
NaH13CO3 (0.06375 mg kg
_1), in order to prime the bicarbonate pool,
which was followed by a [6,6-2H2]glucose prime (13.5 µmol kg
_1).
Thereafter, a continuous infusion of [6,6-2H2]glucose and
[U-13C]palmitate (or [1,2-13C]acetate in the acetate recovery test) was
started (t = 0) via a calibrated IVAC 560 pump (San Diego, CA, USA)
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and continued for 150 min. At t = 60 min subjects started to exercise
on a cycle ergometer at a workload of 40 % Wmax for a 30 min period.
At t = 90 and t = 120 min the exercise intensity was increased to 55
and 75 % Wmax, respectively. When the subjects were at rest, oxygen
uptake (VO2) and carbon dioxide production (VCO2) were measured
continuously (Oxycon-ß; Mijnhardt, Bunnik, The Netherlands).
During exercise, VO2 and VCO2 were measured every 5 min before
sampling breath for the measurement of isotope enrichment. Breath
and blood samples were collected at t = 0, 50, 55 and 60 min during
rest, at t =80, 85 and 90 min during exercise at 40 % Wmax, at t = 110,
115 and 120 min during exercise at 55 % Wmax), and finally at
t = 140, 145 and 150 min during exercise at 75 % Wmax). Percutaneous
muscle biopsy samples (Bergstrom, 1975) were taken from the vastus
lateralis muscle at rest (t = 60 min) and at the end of each exercise
stage (t = 90, 120 and 150 min). Muscle biopsy samples were collected
from both legs. The first two biopsy samples were taken from the
same incision in one leg, and the second two were collected from the
same incision in the contralateral leg. When biopsy samples were
taken from the same incision, the first sample was taken from
different fibres (distal to the incision with the needle pointing
inwards) from the second (proximal to the incision with the needle
pointing outwards).
Tracer infusion
Infusion rates of [U-13C]palmitate and [6,6-2H2]glucose averaged
8.2 ± 0.3 and 261 ± 1.9 nmol kg_1 min_1, respectively. At the onset
of exercise [U-13C]palmitate infusion rates were doubled (16.5 ±
0.5 nmol kg_1 min_1). In the acetate recovery trial, a corresponding
amount of 13C was infused, and [1,2-13C]acetate infusion rates
averaged 63.3 ± 1.9 and 126.6 ± 3.7 nmol kg_1 min_1 during the
resting and exercise periods, respectively. The palmitate tracer (99 %
enriched; Cambridge Isotope Laboratories, Andover, MA, USA) was
dissolved in heated sterile water and passed through a 0.2 µm filter
into 5 % warm human serum albumin to make a 0.670 mM solution.
Both the glucose and acetate tracers (99 % enriched; Cambridge
Isotope Laboratories) were dissolved in 0.9 % saline. Palmitate,
glucose and acetate tracer concentrations in the infusates averaged
0.77 ± 0.02, 16.75 ± 0.70 and 3.32 ± 0.09 mmol l_1, respectively.
Sample collection and analysis
Blood samples (5 ml) were collected in tubes containing EDTA, and
centrifuged at 1000 g at +4 °C for 5 min. Aliquots of plasma were
frozen immediately in liquid nitrogen and stored at _40 °C. Glucose
(Uni Kit III; Roche, Basel, Switzerland), lactate (Gutmann &
Wahlefeld, 1974), FFA (Wako NEFA-C test kit; Wako Chemicals,
Neuss, Germany) and free glycerol concentrations (UV method;
Boehringer, Mannheim, Germany) were analysed with a COBAS
FARA semi-automatic analyser. Muscle biopsy samples (Bergstrom,
1975) were immediately frozen in liquid nitrogen and stored at
_80 °C. Muscle biopsy samples were divided into two parts, of which
one was freeze-dried, dissected free from visible blood and connective
tissue, and powdered. A sample (7–10 mg) of this muscle powder
were then extracted with 0.5 M perchloric acid containing 1 mM
EDTA. After centrifugation (14 000 g), the supernatant was
neutralised with 2.2 M KHCO3 and used for the determination of
muscle phosphocreatine, free creatine, their sum (total creatine),
glycogen (Harris et al. 1974), citrate (Bergmeyer, 1974), lactate
(Harris et al. 1974), free carnitine and acetylcarnitine (Cederblad et
al. 1990) concentrations. Muscle free carnitine and acetylcarnitine
concentrations were corrected for muscle total creatine concentration
for each subject. The remaining portion of frozen wet muscle was
used for the determination of PDC activation status (PDCa;
Constantin-Teodosiu et al. 1991).
Expired gas samples were analysed for 13C/12C ratio by gas
chromatography continuous-flow, isotope-ratio mass spectrometry
(GC-IRMS, MAT 252; Finnigan, Bremen, Germany). For
determination of plasma palmitate and FFA kinetics, FFAs were
extracted from plasma, isolated by thin-layer chromatography, and
derivatised to their methyl esters. Palmitate concentration was
determined on an analytical gas chromatograph with flame
ionisation detection, using heptadecanoic acid as the internal
standard, and on average it comprised 20.51 ± 0.27 % of total FFA.
The isotope tracer/tracee ratio of [U-13C]palmitate was determined
using GC-IRMS (MAT 252; Finnigan). Following derivatisation,
plasma [6,6-2H2]glucose enrichment was determined by electron
ionisation gas chromatography mass spectrometry (INCOS-XL;
Finnigan). Glucose (Uni Kit III) and acetate (kit 148261; Boehringer)
concentration in the infusates were determined with the COBAS
FARA semi-automatic analyser.
Calculations
From respiratory measurements (VO2, VCO2) total fat and carbohydrate
oxidation rates were calculated using the non-protein respiratory
quotient (Peronnet & Massicotte, 1991):
Fat oxidation rate = 1.695 VO2 _ 1.701 VCO2, (1)
Carbohydrate oxidation rate = 4.585 VCO2 _ 3.226 VO2, (2)
with VO2 and VCO2 in litres per minute (l min_1) and oxidation rate in
grams per minute (g min_1). Breath and plasma enrichments are
expressed as the tracer/tracee ratio (TTR);
TTR = (13C/12C)sa _ (
13C/12C)bk, (3)
where sa denotes the sample and bk the background value.
The rate of appearance (Ra) and rate of disappearance (Rd) of
palmitate and glucose were calculated using the single-pool non-
steady-state Steele equations (Steele, 1959) adapted for stable isotope
methodology as described elsewhere (Wolfe & Jahoor, 1990):
F _ V [(C2 + C1)/2][(E2 _ E1)/(t2 _ t1)]Ra = —————————————————, (4)
(E2 + E1)/2
C2 _ C1Rd = Ra _ V ≤————≥, (5)
t2 _ t1
where F is the infusion rate (µmol kg_1 min_1), V is the distribution
volume for palmitate or glucose (40 and 160 ml kg_1, respectively), C1
and C2 are the palmitate or glucose concentrations (mmol l
_1) at times
1 (t1) and 2 (t2), respectively, and E1 and E2 are the plasma palmitate
or glucose enrichments (TTR) at t1 and t2, respectively. 
13CO2
production (Pr13CO2; mol min
_1) from the infused palmitate tracer
was calculated as:
Pr13CO2 = (TTRCO2 w VCO2)/(k w Ar), (6)
where TTRCO2 is the breath 
13C/12C ratio at a given time point, k is the
volume of 1 mol of CO2 (22.4 l mol
_1), and Ar is the fractional 13C label
recovery in breath CO2 after the infusion of labelled acetate,
calculated as:
Ar = [(TTRCO2 w VCO2)/(k w 2F)], (7)
where F is infusion rate of [1,2-13C]acetate (mol min_1). Plasma
palmitate oxidation (Rox; mol min_1) can subsequently be calculated
as:
Rox palmitate = Rd palmitate w (Pr13CO2/F w 16), (8)
where Rd palmitate is the rate of disappearance of palmitate
(mol min_1), F is the palmitate infusion rate (mol min_1) and 16 is the
number of carbon atoms in palmitate. Total plasma FFA oxidation
was calculated by dividing palmitate oxidation rate by the fractional
contribution of plasma palmitate to total plasma FFA concentration.
The contribution of plasma FFA oxidation to total fat oxidation was
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calculated by assuming that the molecular mass of TG equals
860 g mol_1 and that every TG molecule contains three fatty acids.
The contribution of fat sources other than plasma FFA was
calculated by subtracting plasma FFA oxidation from total fat
oxidation.
In a previous study, where we applied both a U-13C-labelled and a
6,6-2H2-labelled glucose tracer (Jeukendrup et al. 1999) during
moderate-intensity exercise, it was shown that the Rd of plasma
glucose measured with [6,6-2H2]glucose was identical to the oxidation
rate of plasma glucose measured as the 13CO2 production during a
[U-13C]glucose infusion. Therefore, plasma glucose oxidation rate was
calculated as:
Rox plasma glucose = Rd plasma glucose. (9)
Muscle glycogen oxidation was calculated by subtracting plasma
glucose oxidation from total carbohydrate oxidation.
Statistics
All data are expressed as means ± S.E.M. To compare tracer kinetics
and oxidation rates of the different substrate sources between resting
and exercise conditions and between the different exercise stages, we
used a two-factor analysis of variance (ANOVA) for repeated
measures. Scheffé’s post hoc test was applied in cases of a significant
(P < 0.05) F ratio to locate the differences. The same statistical
methodology was used to compare muscle and mean plasma
metabolite concentrations. Simple linear regression was used to
investigate the correlation between free carnitine concentration and
the relative contribution of fat oxidation to total energy
expenditure.
RESULTS
Tracer kinetics
Breath 13CO2/
12CO2 ratios, and plasma palmitate
enrichment and concentration are shown in Fig. 1A, B
and C, respectively. As plasma palmitate concentration
showed a small increase with time at each exercise
intensity (Fig. 1C), non-steady-state Steele equations
were applied. With the exception of Ra palmitate at the
75 % Wmax workload, Ra, Rd and Rox palmitate were
significantly higher during exercise compared to resting
values (Table 1). Differences in Ra palmitate between
exercise stages did not reach statistical significance. Rd
and Rox palmitate were significantly lower during the
75 % Wmax compared to the 40 and 55 % Wmax workload,
respectively. The percentage of Ra palmitate oxidised
(% Raox) was higher during exercise compared to resting
values, but no significant differences were observed
between exercise stages (Table 1). Plasma glucose
enrichment and concentration data are shown in Fig. 2A
and B, respectively. Since plasma glucose levels showed a
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Figure 1. Palmitate tracer data
A, breath 13CO2/
12CO2 ratio (mean + S.E.M.); B, plasma [U-
13C]palmitate enrichment (mean + S.E.M.);
C, plasma palmitate level (mean + S.E.M.). TTR, tracer/tracee ratio. * Significantly different from the
mean resting value, † significantly different compared to the mean value observed during exercise at 40 %
of the maximal workload (Wmax), ‡ significantly different from the mean value observed during exercise
at 55 % Wmax (P < 0.05).
Table 1. Tracer kinetics at rest and during cycling exercise at 40, 55 and 75 % of Wmax
Rest 40 % Wmax 55 % Wmax 75 % Wmax
Ra Palmitate 2.83 ± 0.29 4.68 ± 0.38 * 4.53 ± 0.48 * 3.83 ± 0.24
Rd Palmitate 2.67 ± 0.27 4.60 ± 0.37 * 4.38 ± 0.47 * 3.76 ± 0.22 *†
Rox Palmitate 1.02 ± 0.18 3.64 ± 0.41 * 3.86 ± 0.41 * 2.98 ± 0.24 *‡
% Raox Palmitate 34.5 ± 2.96 76.9 ± 4.64 * 85.2 ± 3.47 * 77.9 ± 3.62 *
Ra Glucose 16.9 ± 1.11 25.3 ± 2.12 38.9 ± 2.10 *† 71.8 ± 4.70 *†‡
Rd Glucose 16.6 ± 0.93 24.3 ± 2.33 37.6 ± 1.99*† 66.8 ± 4.64 *†‡
Ra, rate of appearance; Rd, rate of disappearance; Rox, rate of oxidation (µmol kg_1 min_1); % Raox,
percentage Ra palmitate oxidised. Values are expressed as means ± S.E.M. (n = 8). * Significantly
different from resting values (P < 0.05), † significantly different from values at 40 % Wmax workload
(P < 0.05), ‡ significantly different from values at 55 % Wmax workload (P < 0.05).
small increase with time, particularly at the highest
exercise intensity (Fig. 2B), non-steady-state Steele
equations were applied. Ra and Rd glucose showed a non-
significant increase from rest to exercise and were
significantly increased as exercise intensity was further
increased compared to preliminary values at rest and
during exercise (Table 1).
Substrate utilisation
Plasma concentrations of FFA, glycerol and lactate are
shown in Fig. 3. Energy expenditure and the use of
different substrate sources at rest and during exercise are
illustrated in Fig. 4. Oxidation rates of the different
substrates during exercise are summarised in Table 2. The
40, 55 and 75 % Wmax workloads applied in this study
corresponded to 44 ± 1, 57 ± 1 and 72 ± 2 % VO2,max,
respectively. At rest, fat oxidation averaged 0.08 ±
0.02 g min_1 and provided 56 ± 11 % of the total energy
expenditure. Carbohydrate oxidation rate at rest averaged
0.15 ± 0.04 g min_1 (44 ± 11 %). During exercise at 40 %
Wmax, total fat and carbohydrate oxidation rates increased
(0.68 ± 0.11 and 1.44 ± 0.35 g min_1, respectively;
P < 0.05) and provided 55 ± 9 and 46 ± 9 % of the total
energy expenditure, respectively.
Increasing the exercise intensity to 55 % Wmax resulted in
a non-significant increase in total fat and a significant
increase in total carbohydrate oxidation rates (0.79 ±
0.15 g min_1, or 50 ± 9 %, and 2.04 ± 0.41 g min_1, or
51 ± 9 %, respectively). Plasma glucose and muscle
glycogen oxidation rates were significantly higher
compared to the 40 % Wmax workload (Table 2). The
changes in the oxidation rates of FFAs and other fat
sources did not reach statistical significance when
compared to the 40 % Wmax workload (Table 2).
Increasing the exercise intensity up to 75 % Wmax resulted
in a marked decrease in total fat oxidation, both absolute
and relative, compared to that of the other exercise
intensities (0.51 ± 0.14 g min_1, or 24 ± 6 %; P < 0.05).
This decrease was accounted for by significant decreases
in the oxidation rate of both FFAs and other fat sources
compared to the 55 % Wmax workload. Total carbohydrate
oxidation rate markedly increased (3.91 ± 0.32 g min_1,
or 76 ± 6 %; P < 0.05), which was accounted for by
significant increases in both plasma glucose and muscle
glycogen oxidation rates compared to those at the other
workloads (Table 2). Plasma FFA concentration tended to
increase during each exercise stage, but did not differ
between the different exercise intensities, although it
tended to be lower at the highest workload (Fig. 3).
Plasma glycerol concentration was higher during exercise
compared to resting conditions and was significantly
increased at the 75 % Wmax workload compared to that at
the 40 and 55 % Wmax workloads. Plasma lactate levels
increased substantially at the 75 % Wmax workload
(Fig. 3). In the four subjects who performed three
additional trials at 40, 55 and 75 % Wmax, we observed no
significant differences in total fat oxidation rates
compared to the main exercise protocol (0.64 ± 0.06,
0.75 ± 0.10 and 0.35 ± 0.15 g min_1, respectively). The
decrease in the contribution of fat oxidation to total
energy expenditure at the 75 % Wmax workload tended to
be greater under conditions when no preliminary exercise
was performed.
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Figure 2. Glucose tracer data
A, plasma [6,6-2H2]glucose enrichment
(mean + S.E.M.); B, plasma glucose level
(mean + S.E.M.). * Significantly different from
the mean resting value, † significantly different
from the mean value observed during exercise
at 40 % Wmax, ‡ significantly different from the
mean value observed during exercise at 55 %
Wmax (P < 0.05).
Table 2. Contribution of substrates to total energy expenditure during cycling exercise at 40, 55
and 75 % Wmax
40 % Wmax 55 % Wmax 75 % Wmax
Free fatty acids 0.39 ± 0.04 (31 %) 0.41 ± 0.04 (25 %) 0.31 ± 0.02 (15 %) ‡
Other fat sources 0.29 ± 0.05 (24 %) 0.39 ± 0.03 (24 %) 0.20 ± 0.04 (9 %) ‡
Plasma glucose 0.33 ± 0.03 (10 %) 0.51 ± 0.03 (13 %) † 0.90 ± 0.06 (18 %) †‡
Muscle glycogen 1.11 ± 0.12 (35 %) 1.53 ± 0.13 (38 %) † 3.00 ± 0.10 (58 %) †‡
Oxidation rates (g min_1) at 40, 55 and 75 % Wmax are expressed as means ± S.E.M. (n = 8). The percentages
given in parentheses indicate the relative contribution of the substrate source to total energy expenditure.
† Significantly different from the 40 % Wmax workload (P < 0.05), ‡ significantly different from the 55 %
Wmax workload (P < 0.05).
Muscle metabolites
Muscle PDC activation and citrate concentration increased
in parallel with exercise intensity, and after exercise at
75 % Wmax were significantly greater than the resting
values (Table 3). Muscle glycogen concentration decreased
with increasing exercise intensity, but was not significantly
different from the resting concentration until after exercise
at 55 % of Wmax (Table 3). Muscle glycogen concentration
following the exercise at 75 % Wmax was significantly
lower than after exercise at 40 and 55 % Wmax. There was
no significant accumulation of muscle lactate until after
exercise at 55 % Wmax (Table 3). Furthermore, muscle
lactate concentration was greater after exercise at 75 %
Wmax compared with that at rest and at 40 and 55 %
Wmax. Muscle acetylcarnitine concentration increased
with exercise intensity, and free carnitine decreased in a
corresponding manner. As a result, 69 ± 4 % of the total
carnitine pool had become acetylated at the highest
exercise intensity, compared to 13 ± 3 % at rest. The sum
of muscle free carnitine and acetylcarnitine concentration
remained unchanged during exercise.
DISCUSSION
The present study is the first to make use of a
[U-13C]palmitate tracer during incremental exercise in
order to estimate directly plasma FFA oxidation from the
13CO2 production in expired air. Careful corrections were
made for tracer incorporation into TCA cycle metabolites
using an acetate recovery factor (Sidossis et al. 1995a,b;
Schrauwen et al. 1998), with measurements being made at
each exercise intensity. Romijn et al. (1993) have also
presented estimates of the utilisation of different
substrate sources as a function of exercise intensity.
They, however, used [2H2]palmitate and [6,6-
2H2]glucose
tracers and assumed that the Rd of both of these tracers
equalled the oxidation rate (Rox). Therefore, their
reported values for plasma FFA and glucose oxidation
rates were maximal estimates, while their reported values
for muscle glycogen and TG fat source oxidation rate,
both calculated as total macronutrient oxidation minus
oxidation of the plasma source, were minimal estimates.
The present data show clearly that the Rox of palmitate
represented on average 81.7 % of the Rd during exercise
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Figure 3. Blood plasma metabolites
Plasma concentrations of free fatty acids (A), free glycerol (B) and lactate (C; means + S.E.M.) during the
rest period (t = 0–60 min), and exercise at 40 %Wmax (t = 60–90 min), 55 % Wmax (t = 90–120 min) and
75 % Wmax (t = 120–150 min). * Mean plasma level significantly different from the mean resting values,
† mean plasma levels significantly different from the 40 % Wmax values, ‡ mean plasma levels
significantly different from the 55 % Wmax values (P < 0.05).
Table 3. Metabolite concentrations in skeletal muscle at rest and following three 30 min bouts of
exercise at 40, 55 and 75 % of Wmax
Rest 40 % Wmax 55 % Wmax 75 % Wmax
Glycogen 526 ± 22 414 ± 24 386 ± 31 * 200 ± 31 *†‡
Lactate 6.3 ± 0.9 11.5 ± 1.7 15.6 ± 3.4 * 29.5 ± 2.4 *†‡
Citrate 0.84 ± 0.09 1.06 ± 0.15 1.33 ± 0.13 1.39 ± 0.11 *
PDCa 0.57 ± 0.08 1.18 ± 0.10 1.23 ± 0.17 1.67 ± 0.32 *
Free carnitine 15.87 ± 1.17 11.25 ± 1.13 * 10.29 ± 0.84 * 5.61 ± 0.76 *†‡
Acetylcarnitine 2.3 ± 0.4 7.3 ± 1.1 * 8.4 ± 1.3 * 12.5 ± 1.1 *†‡
Total carnitine 18.1 ± 1.1 18.5 ± 0.9 18.7 ± 0.9 18.1 ± 1.0
Values are presented as means ± S.E.M. (n = 8) and are expressed as mmol (kg dry muscle)_1 except for the
transformation of pyruvate dehydrogenase complex (PDC) into its active form (PDCa), which is given in
mmol min_1 (kg wet muscle)_1. * Significantly different from resting values (P < 0.05), † significantly
different from the 40 % Wmax workload (P < 0.05), ‡ significantly different from the 55 % Wmax workload
(P < 0.05).
(Table 1), implying that plasma FFA oxidation has been
overestimated in the past, and conversely that TG
oxidation has been underestimated. Furthermore, the
data show that the contribution of plasma FFA and TG
fat sources was about 50 % each at each exercise intensity.
We also correctly assumed that total fat oxidation minus
plasma FFA oxidation equals the sum of intramuscular
plus lipoprotein-derived TG oxidation, while others (e.g.
Romijn et al. 1993, 1995; Sidossis et al. 1997), for reasons
that are not immediately obvious, excluded lipoprotein-
derived TG as an important energy source during exercise.
Finally, we have recently validated the assumption that
the Rd of glucose equals its oxidation rate during
moderate- to high-intensity exercise (Jeukendrup et al.
1999), indicating that our estimates of blood glucose and
muscle glycogen oxidation are about equal to those
published previously (Romijn et al. 1993).
In order to eliminate day-to-day variations, we quantified
substrate utilisation at different exercise intensities
within a single trial. Furthermore, we investigated
possible accumulative effects of the incremental protocol
on substrate utilisation by asking four of the subjects to
perform three additional single trials at 40, 55 and 75 %
Wmax. There were no differences in total fat and
carbohydrate oxidation rates when comparing these
single trials with the incremental protocol. The relative
decrease in fat oxidation at 75 % Wmax tended to be even
greater when the subjects started exercise at the high-
intensity workload immediately after warming up. This
indicates that emptying of the intramuscular TG stores
did not seem to play a role in the reduction of fat
oxidation observed at 75 % Wmax.
In the present study, total fat and carbohydrate
oxidation rates increased from rest to exercise (Table 2).
However, the relative contribution of fat oxidation to
total energy expenditure did not change from resting
conditions to exercise, and remained unchanged when
exercise was increased up to 55 % Wmax (Fig. 4). No
significant changes were found in the relative
contribution of the different substrate sources to total
energy expenditure. However, as exercise intensity was
further increased up to 75 % Wmax, substrate utilisation
changed markedly. Total body fat oxidation rate
decreased by 34 ± 7 % compared to that at the 55 % Wmax
workload (P < 0.05), and this was accounted for by a
reduction in the oxidation rate of plasma FFAs and of
other fat sources (i.e. the sum of intramuscular and
lipoprotein-derived TG; Table 2 and Fig. 4). A reduction
in plasma FFA availability did not seem to play a role in
reducing fat oxidation rates, as Ra palmitate (Table 1)
and the plasma concentrations of palmitate (Fig. 1) and
total FFAs (Fig. 3) did not decrease significantly at the
highest workload. As blood flow will have been greatest
at the highest exercise intensity, this implies that the
arterial FFA supply will also have been greatest at this
time. In contrast to our data, Romijn et al. (1995)
observed a significant reduction in Ra palmitate during
high-intensity exercise, which may be explained by the
fact that they applied a slightly higher (relative)
workload. However, elevation of plasma FFA availability
by lipid and heparin infusion only partially restored fat
oxidation at the highest exercise intensity (Romijn et al.
1995). Therefore, both studies indicate clearly that the
observed decrease in total fat oxidation cannot be
accounted for by a decreased plasma FFA availability
and that the ‘glucose–FFA cycle’ (Randle et al. 1963) does
not operate during high-intensity exercise.
Suggestions have also been made that the transport of
FFAs across the plasma membrane limits FFA uptake
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Figure 4. Energy expenditure and fuel selection
Values are means. FFA, free fatty acid.
and oxidation by muscle (Bonen et al. 1999, 2000). Three
carrier-mediated transporters for long-chain fatty acids
have been identified in the plasma membrane (Bonen et
al. 1999). Exercise (muscle contraction) has recently been
shown to lead to parallel increases in the translocation of
one of these transporters (fatty acid translocase) from
endosomal membranes to the plasma membrane, and the
fatty acid uptake by giant plasma membrane vesicles in
an intensity-dependent manner (Bonen et al. 2000). This
recent observation makes it unlikely that the reduction in
fat oxidation is caused by a down-regulation of the fatty
acid transport capacity during high-intensity exercise. In
accordance with this, Kiens et al. (1999) observed an
increase in intramyocellular FFA concentration in
humans when exercise intensity was increased from 65 to
90 % VO2,max, implying that the reduction in fat oxidative
capacity during high-intensity exercise is not determined
by a reduced intramyocellular availability of fatty acid.
Sidossis et al. (1997) showed in the setting of a constant
plasma FFA availability that long-chain fatty acid
oxidation, but not medium-chain fatty acid oxidation, is
inhibited during high-intensity exercise and not during
moderate-intensity exercise. These data were taken to
suggest that the decrease in fat oxidation during high-
intensity exercise was the result of a direct inhibition of
long-chain fatty acid entry into the mitochondria
(Sidossis et al. 1997). However, the suggestion that
inhibition of CPT I, by increasing concentrations of
malonyl-CoA, plays a pivotal role in this decrease in fat
oxidation (Sidossis et al. 1997) has not been confirmed by
measurements of malonyl-CoA concentration in rat
(Rasmussen & Winder, 1997; Odland et al. 1998) and
human muscle (Odland et al. 1998). More recently, Dean et
al. (2000) showed that in human skeletal muscle acetyl-
CoA carboxylase activity, and to a lesser extent malonyl-
CoA concentration, actually decreases during exercise,
with the magnitude of the decrease generally paralleling
exercise intensity. Consequently, the observed decrease in
fat oxidation during high-intensity exercise cannot be
attributed to an increase in muscle malonyl-CoA
concentration (Winder & Hardie, 1996; Odland et al.
1998; Winder, 1998; Dean et al. 2000).
We hypothesised that during light- to moderate-
intensity exercise (40 % Wmax), flux through the PDC
reaction would be less than TCA cycle flux, which would
result in minimal acetylation of the carnitine pool. With
increasing exercise intensity up to a moderate workload
(55 % Wmax), glycolytic and PDC flux would only be
marginally greater than the flux through the TCA cycle,
resulting in some muscle lactate and acetylcarnitine
accumulation. In contrast, during high-intensity exercise
(75 % Wmax), flux through the glycolytic pathway and the
PDC reaction would greatly exceed flux through the TCA
cycle, thereby markedly increasing muscle lactate and
acetylcarnitine concentrations and reducing free
carnitine availability. With this in mind, we designed an
experimental protocol to test the hypothesis that the
expected reduction in fat oxidation during high-intensity
exercise would coincide with a marked increase in
glycolytic and PDC flux, leading to a marked decrease in
muscle free carnitine availability. We further hypothesised
that this decrease in free carnitine availability could
possibly be directly responsible for the decreased fat
oxidation, by limiting long-chain fatty acid entry into
the mitochondria. In support of this hypothesis, the data
from the present study clearly show marked increases in
glycolytic and PDC flux (Table 3) with increasing exercise
intensity, which are paralleled by a marked decline in
muscle free carnitine availability (Table 3) and a
concomitant decrease in fat oxidation (Fig. 4). Many of
these observations have been published before as isolated
findings (Harris et al. 1987; Hiatt et al. 1989; Sahlin,
1990; Constantin-Teodosiu et al. 1991; Dyck et al. 1993;
Howlett et al. 1998), but this is the first study to utilise a
fully integrated approach measuring both substrate flux
using contemporary stable isotope tracer methodology
and quantitative intermediary metabolism in muscle.
The key question is whether the observed decrease in
whole-muscle free carnitine concentration was sufficient
to reduce CPT I activity. The muscle free carnitine
concentration in the present study decreased to
5.6 ± 0.8 mmol (kg dry muscle)_1 (Table 3) or 1.25 ±
0.16 mmol (kg wet muscle)_1. In addition, it is likely that
during exercise the concentration of free carnitine in type
I fibres was much lower than that measured in mixed-
fibre muscle (Constantin-Teodosiu et al. 1996). Therefore,
muscle carnitine concentration at the highest workload
approaches the reported Km of CPT I for free carnitine
measured in human skeletal muscle (0.480 mM; McGarry
et al. 1989), and probably reached the Km value in type I
fibres. We do not know the local carnitine concentration
seen by CPT I in the space between the outer and inner
mitochondrial membranes (CPT I is located on the outer
side of the inner mitochondrial membrane; Zammit,
1999). Nevertheless, most of the carnitine in skeletal and
heart muscle seems to be present in the cytosol (Oram et
al. 1975; Zammit, 1999), implying that the cytosolic
concentration will be close to the whole-tissue
concentration. Therefore, the concentration surrounding
the CPT I complex may be lower than the cytosolic
concentration. In short, the possibility cannot be
excluded that during high-intensity exercise the free
carnitine concentration declines to a value that could
limit CPT I activity and reduce long-chain fatty acid
oxidation. Muscle free carnitine concentration in these
healthy subjects during high-intensity exercise ranged
from 21 to 55 % of the resting concentration. It is worth
noting that in patients with myopathic carnitine
deficiency (a genetic defect that manifests itself clinically
as muscle weakness, exercise intolerance and excessive
lipid accumulation in skeletal muscle; Engel & Angelini,
1973; Di Mauro et al. 1980; Siliprandi et al. 1989), the
muscle free carnitine concentration ranges from 5 to 32 %
of that of controls.
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The observed decline in muscle free carnitine and parallel
rise in acetylcarnitine concentration seems to be
intrinsically related to a decrease in CoASH concentration
in muscle, as this has been shown in both human and
equine muscle (Carlin et al. 1990; Constantin-Teodosiu et
al. 1991). As most of the CoASH is apparently present in
the mitochondrial matrix (Oram et al. 1975; Zammit,
1999), this implies that the availability of mitochondrial
CoASH could also limit the rate of b-oxidation during
high-intensity exercise. However, assuming that PDC
was fully activated at the highest workload in the present
study, it can be calculated that the entire pool of cellular
CoASH would have become acetylated within 1 s of the
initiation of contraction. If this were to occur, the
immediate result would be the total inhibition of
b-oxidation. An interesting alternative mechanism
leading to a down-regulation of CPT I at high exercise
intensities has recently been proposed by Starritt et al.
(2000). A decrease of the pH from 7.0 to 6.8 substantially
reduced CPT I activity measured in vitro. However, the
relevance of this to the in vivo situation remains to be
established.
In conclusion, this study showed that both carbohydrate
and fat oxidation rates increased proportionally as the
exercise intensity was increased up to a workload of 55 %
Wmax. However, as exercise intensity was increased to
75 % Wmax, both muscle glycogen and plasma glucose
oxidation rate markedly increased and fat oxidation rate
markedly decreased. This decrease in fat oxidation rate
involved a significant decline in the oxidation rate of both
plasma FFAs and TG fat sources (sum of intramuscular
and lipoprotein-derived TG). Furthermore, the decrease
in plasma FFA oxidation was not a consequence of a
decrease in plasma FFA availability. We propose that a
mechanism involving the down-regulation of CPT I,
either by a decrease in free carnitine availability or by a
decrease in pH, is the most likely candidate to lead to the
reduction in fat oxidation during high-intensity exercise.
We would like to propose that this mechanism is relevant
to the impairment of fat oxidation seen during exercise in
diabetic and obese subjects, as the increase in glycolytic
flux is excessive in these subjects at relatively low
absolute workloads.
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